MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0109986
Sinterx Pharma Private Limited
Sinterx Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹74.65 Cr
▲ 172.73% YoY
Net profit · FY 2025
₹8.52 Cr
Net margin 11.4%
EBITDA · FY 2025
₹12.04 Cr
EBITDA margin 16.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7.5 Lakh
Issued & subscribed
Open charges
₹27 Cr
Satisfied ₹4.05 Cr
Company age
5 yrs
Est. 2021
Employees · EPFO
12
Provident fund records
About Sinterx Pharma Private Limited
Data last updated:
Sinterx Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2021PTC154397. Its GSTIN is 36ABGCS7267P1ZF (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.5 Lakh. It is led by directors including Sruthi Medapati and Deepika Punnapu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹74.65 Cr. For the same year it recorded a net profit of ₹8.52 Cr (net margin 11.4%) and EBITDA of ₹12.04 Cr (EBITDA margin 16.1%). Revenue has grown at a compounded annual rate (CAGR) of 66% over three years.
The company has about 12 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹27 Cr and satisfied charges of ₹4.05 Cr on record.
Sinterx Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0109986).
Company details
CIN U24299TG2021PTC154397
Registration Number 154397
Incorporation Date 26 August 2021
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-TS-02-0109986
Recognitions & Rankings of Sinterx Pharma
Contact details
Sinterx Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No 201 Sai Acrade Plot No.18, Survey No.66/2 Raidurgam, Hyderabad, Telangana, India – 500032
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sinterx Pharma Private Limited, buy the company report.
Comprehensive company report
Sinterx Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sinterx Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sinterx Pharma Private Limited, buy the company report.
Financials of Sinterx Pharma Private Limited
FY 2025 filings availableSinterx Pharma Private Limited reported revenue of ₹74.65 Cr for FY 2025.
Revenue · FY 2025
₹74.65 Cr
Net profit · FY 2025
₹8.52 Cr margin 11.4%
EBITDA · FY 2025
₹12.04 Cr margin 16.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 66%
EBITDA CAGR growth
1 year
▼ 15%
3 years · compounded
▲ 122%
Revenue has grown at a compounded annual rate (CAGR) of 66% over three years. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹12.04 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹8.52 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 16.1% | |||
| Net Profit Margin | 11.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Sinterx Pharma Private Limited, buy the company report.
Board of directors of Sinterx Pharma Private Limited
Sinterx Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sruthi Medapati | Director | 26 Aug 2021 | 5 Years 2 Months | Current |
| Deepika Punnapu | Director | 26 Aug 2022 | 4 Years 2 Months | Current |
| Golla Padmavathi | Director | 01 Dec 2021 | 4 Years 10 Months | Current |
Peer comparison
Sinterx Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kerala State Industrial Enterprises Ltd | ₹74.88 Cr (FY 2025) | 1.0% | Thiruvananthapuram, Kerala, India | |||
| Seutic Labs Private Limited | ₹74.85 Cr (FY 2025) | -28.0% | Hyderabad, Telangana, India | |||
| Atlas Pharmachem Industries Private Limited | ₹74.83 Cr (FY 2025) | 5.0% | Ahmedabad, Gujarat, India | |||
| Kaysons Pigments Private Limited | ₹74.8 Cr (FY 2025) | 18.0% | New Delhi, Delhi, India | |||
| Hoster Labs Private Limited | ₹74.69 Cr (FY 2024) | 0.0% | Hyderabad, Telangana, India | |||
| Sinterx Pharma Private Limitedthis company | ₹74.65 Cr (FY 2025) | ₹8.52 Cr | 11.4% | 12 | Hyderabad, Telangana, India | |
| Diamines and Chemicals Limited | ₹74.65 Cr (FY 2025) | -30.0% | Vadodara, Gujarat, India | |||
| Pi Kumiai Private Limited | ₹74.61 Cr (FY 2025) | -5.0% | Gurugram, Haryana, India | |||
| Astron International Private Limited | ₹74.55 Cr (FY 2025) | -7.0% | Ahemedabad, Gujarat, India | |||
| Avensis Crop Science Private Limited | ₹74.46 Cr (FY 2025) | 18.0% | Samba, Jammu and Kashmir, India | |||
| Aswini Homeo and Ayurvedic Products Private Limited | ₹74.43 Cr (FY 2024) | -2.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Sinterx Pharma Private Limited, buy the company report.
Auditor
Sinterx Pharma Private Limited is audited by SARATH & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SARATH & ASSOCIATES | FY 2023 | 005120S |
Shareholding
The shareholding of Sinterx Pharma Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Sinterx Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹27 Cr
Satisfied charges
₹4.05 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Aug 2025 | 101157841 | Others | ₹25 Cr | Open | |
| 14 Aug 2025 | 101162171 | Others | ₹2 Cr | Open | |
| 23 Aug 2024 | 100979731 | Axis Bank Limited | ₹4.05 Cr | Satisfied |
To see the full charge records of Sinterx Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Sinterx Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sinterx Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sinterx Pharma Private Limited has a workforce of 12 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
Employee count
12
Active EPFO establishments
1
Employee growth
20%
GST
Sinterx Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABGCS7267P1ZF | Telangana | Active | 23 Sep 2021 |
To see the full GST registrations and return filing status of Sinterx Pharma Private Limited, buy the company report.
Recent activity
Sinterx Pharma Private Limited has 6 board changes on record since 2021: 3 appointments and 3 cessations. The latest: Srinivas Reddy Karka ceased to be Director on 07 Jan 2023.
AGM
Sinterx Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 2,500.00 Lakh with Charge ID 101157841 was registered on 14 Aug 2025.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 101162171 was registered on 14 Aug 2025.
Charges
A charge registered on 23 Aug 2024 via Charge ID 100979731 with Axis Bank Limited was fully satisfied on 11 Aug 2025.
Filing
Sinterx Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited amounted to Rs. 405.00 Lakh with Charge ID 100979731 was registered on 23 Aug 2024.
Ceased
Srinivas Reddy Karka ceased to be Director.
Ceased
Golla Padmavathi ceased to be Additional Director.
Appointed
Deepika Punnapu was appointed as Director.
Ceased
Lavanya Angadi ceased to be Director.
Appointed
Golla Padmavathi was appointed as Director.
Appointed
Sruthi Medapati was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Sinterx Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 August 2021 (5+ years old) and is registered under CIN U24299TG2021PTC154397.
Sinterx Pharma has 3 current directors:
- Sruthi Medapati - Director
- Deepika Punnapu - Director
- Golla Padmavathi - Director
The latest financial statements of Sinterx Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Sinterx Pharma is 36ABGCS7267P1ZF, registered in Telangana.
The CIN (Corporate Identification Number) of Sinterx Pharma is U24299TG2021PTC154397. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sinterx Pharma was incorporated on 26 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sinterx Pharma by revenue are Kerala State Industrial Enterprises Ltd, Seutic Labs Private Limited, Atlas Pharmachem Industries Private Limited, Kaysons Pigments Private Limited, Hoster Labs Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Srinivas Reddy Karka ceased to be Director on 07 Jan 2023. Golla Padmavathi ceased to be Additional Director on 31 Oct 2022. Deepika Punnapu was appointed as Director on 26 Aug 2022. Sinterx Pharma has 6 board changes on record in total.
Yes, Sinterx Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0109986).
The registered office of Sinterx Pharma is at Flat No 201 Sai Acrade Plot No.18, Survey No.662 Raidurgam, Hyderabad, Telangana, India – 500032.
Sinterx Pharma operates in the pharma industry, in the drug formulation and development segment.